© 2023 MJH Life Sciences™ and Managed Healthcare Executive. All rights reserved.
Dermatology
Understanding Vitiligo | A Managed Healthcare Executive K-Cast
December 19, 2022
In this Managed Healthcare Executive® K-Cast, David Rosmarin, M.D., vice chair of education and research in the Department of Dermatology at Tufts Medical Center in Boston, discussed the economic burden, treatment goals, treatment options and health insurance issues related to vitiligo.
Studies Find High Prevalence of Suicidal Ideation in Patients with Vitiligo
December 16, 2022
Because vitiligo affects appearance, people with vitiligo are disproportionately affected by psychiatric conditions, including depression.
Vitiligo. It Is Not Just a Skin Condition
December 15, 2022
The melanocytes attacked by the autoimmune disease are present in the eyes and ears, not just the skin, so vitiligo can adversely affect vision and hearing.
Express Scripts Adds Zorvye, Novel Psoriasis Treatment, to Formulary
November 21, 2022
Formulary placement is crucial to the commercial success of newly approved products, so Acrutis put out a press release last week announcing that Express Scripts had put Zoryve (roflumilast), the company's PDE4 inhibitor cream for plaque psoriasis, on its formulary.
Vitiligo, Systemic Sclerosis Are Linked, Study Finds
November 18, 2022
Israeli researchers find more than a fivefold risk of developing systemic sclerosis among people with vitiligo.
Non-invasive Test That May Help Predict Eczema in Babies
November 18, 2022
Results from the test reveal that high levels of the immune biomarker Thymus and Activation-Regulated Chemokine (TARC) in babies increases their chances of developing atopic dermatitis.
Simvastatin Can Be Effective in Treating Vitiligo Patients with Dyslipidemia
November 17, 2022
Taking 80 mg of the high-cholesterol statin drug daily can control patients' vitiligo activity and protect them against the hazardous effects of dyslipidemia.
Thyroid Abnormalities Rare Among Children with Vitiligo, Study Finds
September 26, 2022
The search for the causes of vitiligo continues. The findings in this study stand in contrast to another one conducted in eastern China that showed a high percentage of children with vitiligo had thyroid abnormalities.
The Other JAK Inhibitors for Vitiligo
September 26, 2022
A recent review article lists six other JAK inhibitors that might be used as treatments for vitiligo in addition to ruxolitinib, the active ingredient in recently approved Opzelura.
At-home Vitiligo Phototherapy Has More Patient Adherence Over Hospital-based Use
September 26, 2022
While phototherapy has been shown to have a positive effect on vitiligo as it works to reduce or prevent the destruction of skin cells, treatment done in the hospital can be long-term and require a number of visits.